235 related articles for article (PubMed ID: 28388932)
1. The efficacy of sodium benzoate as an adjunctive treatment in early psychosis - CADENCE-BZ: study protocol for a randomized controlled trial.
Ryan A; Baker A; Dark F; Foley S; Gordon A; Hatherill S; Stathis S; Saha S; Bruxner G; Beckman M; Richardson D; Berk M; Dean O; McGrath J; Group CW; Scott J
Trials; 2017 Apr; 18(1):165. PubMed ID: 28388932
[TBL] [Abstract][Full Text] [Related]
2. Effect of Sodium Benzoate vs Placebo Among Individuals With Early Psychosis: A Randomized Clinical Trial.
Scott JG; Baker A; Lim CCW; Foley S; Dark F; Gordon A; Ward D; Richardson D; Bruxner G; Beckmann KM; Hatherill S; Stathis S; Dixon K; Ryan AE; McWhinney BC; Ungerer JPJ; Berk M; Dean OM; Saha S; McGrath J
JAMA Netw Open; 2020 Nov; 3(11):e2024335. PubMed ID: 33170261
[TBL] [Abstract][Full Text] [Related]
3. Protocol update and statistical analysis plan for CADENCE-BZ: a randomized clinical trial to assess the efficacy of sodium benzoate as an adjunctive treatment in early psychosis.
Lim C; Baker A; Saha S; Foley S; Gordon A; Ward D; Burgher B; Dark F; Beckmann M; Stathis S; Bruxner G; Ryan A; Richardson D; Hatherill S; Berk M; Dean O; McGrath J; ; Scott J
Trials; 2019 Apr; 20(1):203. PubMed ID: 30961658
[TBL] [Abstract][Full Text] [Related]
4. Cadence discovery: study protocol for a dose-finding and mechanism of action clinical trial of sodium benzoate in people with treatment-refractory schizophrenia.
Baker A; Clarke L; Donovan P; P J Ungerer J; Hartel G; Bruxner G; Cocchi L; Gordon A; Moudgil V; Robinson G; Roy D; Sohal R; Whittle E; Scott JG
Trials; 2021 Dec; 22(1):918. PubMed ID: 34903265
[TBL] [Abstract][Full Text] [Related]
5. Add-on treatment of benzoate for schizophrenia: a randomized, double-blind, placebo-controlled trial of D-amino acid oxidase inhibitor.
Lane HY; Lin CH; Green MF; Hellemann G; Huang CC; Chen PW; Tun R; Chang YC; Tsai GE
JAMA Psychiatry; 2013 Dec; 70(12):1267-75. PubMed ID: 24089054
[TBL] [Abstract][Full Text] [Related]
6. Vitamin D supplementation compared to placebo in people with First Episode psychosis - Neuroprotection Design (DFEND): a protocol for a randomised, double-blind, placebo-controlled, parallel-group trial.
Gaughran F; Stringer D; Berk M; Smith S; Taylor D; Whiskey E; Landau S; Murray R; McGuire P; Gardner-Sood P; Wojewodka G; Ciufolini S; Jordan H; Clarke J; Allen L; Krivoy A; Stubbs B; Lowe P; Arbuthnott M; Rathod S; Boardman A; Firdosi M; McGrath JJ
Trials; 2020 Jan; 21(1):14. PubMed ID: 31907006
[TBL] [Abstract][Full Text] [Related]
7. Sodium Benzoate, a D-Amino Acid Oxidase Inhibitor, Added to Clozapine for the Treatment of Schizophrenia: A Randomized, Double-Blind, Placebo-Controlled Trial.
Lin CH; Lin CH; Chang YC; Huang YJ; Chen PW; Yang HT; Lane HY
Biol Psychiatry; 2018 Sep; 84(6):422-432. PubMed ID: 29397899
[TBL] [Abstract][Full Text] [Related]
8. Effect of Adjunctive Raloxifene Therapy on Severity of Refractory Schizophrenia in Women: A Randomized Clinical Trial.
Kulkarni J; Gavrilidis E; Gwini SM; Worsley R; Grigg J; Warren A; Gurvich C; Gilbert H; Berk M; Davis SR
JAMA Psychiatry; 2016 Sep; 73(9):947-54. PubMed ID: 27438995
[TBL] [Abstract][Full Text] [Related]
9. ENACT: a protocol for a randomised placebo-controlled trial investigating the efficacy and mechanisms of action of adjunctive N-acetylcysteine for first-episode psychosis.
Cotton SM; Berk M; Watson A; Wood S; Allott K; Bartholomeusz CF; Bortolasci CC; Walder K; O'Donoghue B; Dean OM; Chanen A; Amminger GP; McGorry PD; Burnside A; Uren J; Ratheesh A; Dodd S
Trials; 2019 Nov; 20(1):658. PubMed ID: 31779696
[TBL] [Abstract][Full Text] [Related]
10. [Minor neurological and physical anomalies in patients with first-episode psychosis].
Mhalla A; Boussaïd N; Gassab L; Gaha L; Mechri A
Encephale; 2013 Jun; 39(3):149-54. PubMed ID: 23095597
[TBL] [Abstract][Full Text] [Related]
11. Efficacy and safety of ziprasidone in the treatment of first-episode psychosis: an 8-week, open-label, multicenter trial.
Zhao T; Park TW; Yang JC; Huang GB; Kim MG; Lee KH; Chung YC
Int Clin Psychopharmacol; 2012 Jul; 27(4):184-90. PubMed ID: 22426471
[TBL] [Abstract][Full Text] [Related]
12. Integrated treatment of first episode psychosis with online training (e-learning): study protocol for a randomised controlled trial.
Barbeito S; Vega P; Ruiz de Azua S; Balanza-Martinez V; Colom F; Lorente E; Luengo A; Cerrillo E; Crespo JM; González Pinto A
Trials; 2014 Oct; 15():416. PubMed ID: 25348346
[TBL] [Abstract][Full Text] [Related]
13. A randomised, double-blind, placebo-controlled trial of minocycline and/or omega-3 fatty acids added to treatment as usual for at-risk mental states (NAYAB): study protocol.
Qurashi I; Chaudhry IB; Khoso AB; Farooque S; Lane S; Husain MO; Chu S; Sarginson J; Hamarani M; Naqvi HA; Razzaque B; Minhas FA; Yung AR; Deakin JFW; Husain N
Trials; 2017 Nov; 18(1):524. PubMed ID: 29121974
[TBL] [Abstract][Full Text] [Related]
14. The retinoid X receptor agonist bexarotene relieves positive symptoms of schizophrenia: a 6-week, randomized, double-blind, placebo-controlled multicenter trial.
Lerner V; Miodownik C; Gibel A; Sirota P; Bush I; Elliot H; Benatov R; Ritsner MS
J Clin Psychiatry; 2013 Dec; 74(12):1224-32. PubMed ID: 24434091
[TBL] [Abstract][Full Text] [Related]
15. Aripiprazole for the treatment of psychoses in institutionalized patients with Alzheimer dementia: a multicenter, randomized, double-blind, placebo-controlled assessment of three fixed doses.
Mintzer JE; Tune LE; Breder CD; Swanink R; Marcus RN; McQuade RD; Forbes A
Am J Geriatr Psychiatry; 2007 Nov; 15(11):918-31. PubMed ID: 17974864
[TBL] [Abstract][Full Text] [Related]
16. Adjunctive Taurine in First-Episode Psychosis: A Phase 2, Double-Blind, Randomized, Placebo-Controlled Study.
O'Donnell CP; Allott KA; Murphy BP; Yuen HP; Proffitt TM; Papas A; Moral J; Pham T; O'Regan MK; Phassouliotis C; Simpson R; McGorry PD
J Clin Psychiatry; 2016 Dec; 77(12):e1610-e1617. PubMed ID: 27835719
[TBL] [Abstract][Full Text] [Related]
17. COllaborative Shared care to IMprove Psychosis Outcome (COSIMPO): study protocol for a randomized controlled trial.
Gureje O; Makanjuola V; Kola L; Yusuf B; Price L; Esan O; Oladeji BD; Appiah-Poku J; Haris B; Othieno C; Seedat S
Trials; 2017 Oct; 18(1):462. PubMed ID: 29017605
[TBL] [Abstract][Full Text] [Related]
18. Raloxifene Plus Antipsychotics Versus Placebo Plus Antipsychotics in Severely Ill Decompensated Postmenopausal Women With Schizophrenia or Schizoaffective Disorder: A Randomized Controlled Trial.
Weiser M; Levi L; Burshtein S; Hagin M; Matei VP; Podea D; Micluția I; Tiugan A; Păcală B; Grecu IG; Noy A; Zamora D; Davis JM
J Clin Psychiatry; 2017 Jul; 78(7):e758-e765. PubMed ID: 28541645
[TBL] [Abstract][Full Text] [Related]
19. Efficacy of iloperidone in the short-term treatment of schizophrenia: a post hoc analysis of pooled patient data from four phase III, placebo- and active-controlled trials.
Citrome L; Meng X; Hochfeld M; Stahl SM
Hum Psychopharmacol; 2012 Jan; 27(1):24-32. PubMed ID: 22161738
[TBL] [Abstract][Full Text] [Related]
20. Olanzapine-divalproex combination versus divalproex monotherapy in the treatment of bipolar mixed episodes: a double-blind, placebo-controlled study.
Houston JP; Tohen M; Degenhardt EK; Jamal HH; Liu LL; Ketter TA
J Clin Psychiatry; 2009 Nov; 70(11):1540-7. PubMed ID: 19778495
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
